HOME >> MEDICINE >> NEWS
Confidentiality and privacy of personal health information is critical to acceptance of NHIN

Washington -- "ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care," Michael H. Zaroukian, MD, PhD, FACP, told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality today at their hearing on "Consumer Controls for Sensitive Health Records."

Dr. Zaroukian is a member of ACPs Medical Informatics Subcommittee and Medical Director of the Michigan State University (MSU) Internal Medicine Clinic and the Universitys Chief Medical Information Officer. He spoke with the subcommittee by phone.

"Control of content and access by individuals to clinical information are critical issues that will greatly influence acceptance and use of the National Health Information Network (NHIN)," Dr. Zaroukian continued. "The impact of policies adopted and implemented to address these complex concerns could be substantial with respect to the accuracy, reliability and usability of information exchanged electronically."

Dr. Zaroukian responded to a June 2006 report to Health and Human Services Secretary Leavitt that raised questions about the practical implications of policy decisions regarding an individuals right to control access to his or her personal health record through the NHIN.

"Individuals should be able to access their health and medical data conveniently, reliably and affordably," Dr. Zaroukian recommended. "Further, individuals should be able to review which entities and providers have accessed their personal health information."

Dr. Zaroukian suggested that the NHIN use role-based access models to determine the level of information provided to any entity accessing a personal health record. A role-based model would use privacy algorithms such as the title of the requestor, role of the requestor, and source and type request to determine the level of clinical information provided. This model would also allow fo
'"/>

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians
17-Apr-2007


Page: 1 2

Related medicine news :

1. Implantable chips bear promise, but privacy standards needed
2. Medical privacy vs. health care quality?
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
5. Monthly interpersonal psychotherapy prevents relapse of depression in many women
6. The Clorox companys new personal care product lends a hand
7. Importance of personal health records draws support of American College of Physicians
8. U of MN study shows Twin Cities residents get exercise through personal lifestyle activities
9. Combination of personality traits increases risk for heart disease
10. Decision-making impairment appears greater in alcoholics with coexisting personality disorders
11. OHSU Cancer Institute study points to future of personalized medicine

Post Your Comments:
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, ... Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can help ... , Annually, more than 8.6 million adverse drug events are reported in ...
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... Los Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... emergency dental services to help patients in need. Most people know that general health ... hospital emergency. Unfortunately, a fewer amount of people know where to turn to during ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, ... contract lifecycle management solution, as well as announced the date of its next ... and ease of contract management tasks as well as enhancements to the customer ...
(Date:8/3/2015)... ... August 03, 2015 , ... Results ... Navigant Center for Healthcare Research and Policy Analysis show widespread support for the ... said they agreed or strongly agreed that the controversial law passed in 2010 ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3
(Date:8/3/2015)... August 3, 2015 /OFF ... Group LLC, PIV757417 The following release: "Biotech Advancements ... Drug Products & Treatments for Critical-Care Patients With ... time: 3 Aug 2015 12:30 GMT ... military surgical research and top-tier universities for identifying ...
(Date:8/3/2015)... Fla. , Aug. 3, 2015  Charleston ... initiation of its second clinical development program with ... candidate, CL-H1T.  CL-H1T contains fast-dissolving ... being developed as a treatment for migraine headache ... "Many patients with migraine headaches also ...
(Date:8/3/2015)... ZIONA, Israel , August 3, ... TASE: BVXV) today announced it received the statistical analysis of ... vaccine (M-001), administered in the BVX-005 phase II trial which ... future strains which did not exist at the time of ... (flu) strain that caused the epidemic in the ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
Cached News: